10-Q: James River Group Q2 2026: Underwriting Loss Widens

James River Group Holdings, Inc. reported a net loss from continuing operations of $2.2 million for the six months ended June 30, 2026, a significant downturn from the prior year's profit, driven by increased underwriting losses.

Summary

• James River Group Holdings, Inc. reported a net loss from continuing operations of $2.2 million for the first six months of 2026, a substantial decrease from a net income of $16.1 million in the same period of 2025.
• Underwriting results for the first six months of 2026 showed a loss of $6.5 million, with a combined ratio of 102.4%, compared to an underwriting profit of $2.8 million and a combined ratio of 99.1% in the prior year.
• Gross written premiums decreased by 24.9% to $505.3 million for the first six months of 2026 compared to $672.4 million in the prior year, primarily due to a significant reduction in the Specialty Admitted Insurance segment.
• Net investment income increased slightly to $41.6 million for the first six months of 2026 from $40.5 million in the prior year, driven by higher income from fixed maturities and private investments.
• The company's Excess & Surplus Lines segment experienced a decline in underwriting profit, while the Specialty Admitted Insurance segment reported increased underwriting losses.
• The company's A.M. Best financial strength rating remains A- (Excellent) but with a negative outlook, which could impact its ability to attract and retain business if sustained.

Sentiment

Score: 3

Explanation: StockSavvy.ai views this filing as having a negative sentiment due to a significant decline in underwriting profit and a net loss from continuing operations, despite some positive investment income.

Positives

• Net investment income increased slightly to $41.6 million for the first six months of 2026 from $40.5 million in the prior year.
• The company's Excess & Surplus Lines segment maintained a combined ratio below 100% for the three-month period (92.8%), indicating profitability in that segment.
• The company's fixed maturity securities portfolio remains entirely investment grade (BBB- or better) by Standard & Poor's.
• The company's leverage ratio of 27.6% at June 30, 2026, is well within the maximum permitted ratio of 35.0%.

Negatives

• The company reported a net loss from continuing operations of $2.2 million for the six months ended June 30, 2026, compared to a net income of $16.1 million in the prior year.
• Underwriting results for the six months ended June 30, 2026, showed a loss of $6.5 million with a combined ratio of 102.4%, deteriorating from a profit of $2.8 million and a combined ratio of 99.1% in the prior year.
• Gross written premiums decreased by 24.9% for the six months ended June 30, 2026, reflecting a significant decline in the Specialty Admitted Insurance segment.
• The company's A.M. Best rating outlook is negative, which could lead to downgrades and negatively impact business acquisition.
• Goodwill impairment testing revealed that the fair value of the Excess & Surplus Lines reporting unit exceeded its carrying value by less than 3% as of June 30, 2026, indicating increased risk of future impairment.

Risks

• The company may be unable to obtain reinsurance coverage at reasonable prices or on acceptable terms, potentially limiting its ability to manage volatility, mitigate losses, and grow.
• Continued adverse market conditions, a decline in stock price, or reduced future cash flows could lead to goodwill impairment, adversely affecting financial condition and results.
• The negative outlook on the A.M. Best rating could lead to downgrades, materially affecting the company's ability to write new business.
• Gaps in reinsurance protection, due to exclusions or limitations in treaties, expose the company to greater risk and potential losses, including from catastrophic events or terrorist acts.
• The company has credit exposure to Rasier and Aleka under indemnity agreements and loss portfolio transfers if estimated losses grow faster than collateral balances or if recovery estimates are too low.

Future Outlook

The company's financial performance in the first half of 2026 indicates a challenging period with increased underwriting losses and a net loss from continuing operations. The company is focused on underwriting guidelines and profitable growth, but faces competitive markets and potential impacts from its negative A.M. Best outlook.

Management Comments

• We seek to generate compelling returns on tangible common equity while limiting underwriting and investment volatility.
• Markets are extremely competitive and we remain focused on our underwriting guidelines, prioritizing profitable growth in small to medium sized accounts.
• We are closely managing expenses for the segment.

Industry Context

StockSavvy.ai notes that the insurance industry, particularly the specialty and excess & surplus lines segments, is highly competitive. James River Group's results reflect this competitive pressure, with a decline in gross written premiums and increased expense ratios, partly due to program non-renewals and a strategic decision to retain more business, which impacts short-term profitability metrics.

Comparison to Industry Standards

• James River Group's combined ratio of 102.4% for the first six months of 2026 is above the general industry benchmark of below 100% for profitability, indicating an underwriting loss.
• The company's net retention for the Excess & Surplus Lines segment increased to 57.6% for the first six months of 2026 from 54.8% in the prior year, suggesting a strategy to retain more risk, which can impact short-term profitability but potentially increase long-term returns if managed effectively.
• The slight increase in net investment income is consistent with a general trend of higher interest rates benefiting investment portfolios, though the company's private investments showed a decline in income.

Legal Proceedings

• The company is involved in various legal proceedings, including commercial matters and litigation regarding insurance claims, which it believes will not have a material adverse effect.
• A lawsuit filed by Fleming against JRG Holdings and certain officers related to the JRG Re sale is ongoing, with the company vigorously defending itself.
• The company is pursuing damages from Fleming for breach of the Stock Purchase Agreement related to the JRG Re sale.

Related Party Transactions

• The company has a Series A Preferred Share agreement with GPC Partners Investments (Thames) LP, an affiliate of Gallatin Point Capital LLC, which includes dividend rights and conversion provisions.
• The company has indemnity agreements with Rasier (non-insurance entities) and a loss portfolio transfer with Aleka Insurance, Inc., an affiliate of Rasier LLC, related to legacy commercial auto policies.

Stakeholder Impact

• Shareholders may be impacted by the net loss and reduced profitability, potentially affecting stock price.
• Policyholders are generally protected by the company's A- (Excellent) financial strength rating, though the negative outlook introduces some uncertainty.
• Brokers and agents may be affected by the company's competitive positioning and the negative A.M. Best outlook, potentially impacting business acquisition.

Next Steps

• Continue to focus on underwriting guidelines and profitable growth in small to medium-sized accounts within the Excess & Surplus Lines segment.
• Closely manage expenses within the Specialty Admitted Insurance segment.
• Monitor the impact of the negative A.M. Best outlook and potential rating downgrades.
• Continue to monitor goodwill for potential impairment, especially given the narrow margin by which fair value exceeded carrying value for the Excess & Surplus Lines reporting unit.

Key Dates

Recommendation

The filing indicates a significant deterioration in financial performance, with a shift from profit to a net loss from continuing operations and a widening underwriting loss. The combined ratio exceeding 100% and the negative outlook on the A.M. Best rating are concerning indicators. While investment income provides some offset, the core insurance operations are underperforming, suggesting a sell recommendation.

Keywords

insurance, specialty insurance, excess and surplus lines, underwriting profit, loss ratio, combined ratio, investment income, reinsurance